Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Published December 25, 2024 · Recall initiated: November 22, 2024
Summary
FDA records drug Class II recall D-0150-2025, published December 25, 2024 and initiated November 22, 2024. Recalling firm: Provepharm Inc.; Status: Ongoing; Reported quantity: 2160 packs/5 ampules per pack = 10,800 ampules; Lot: Lot #: F9026F01, F9026F02, Exp. Date 12/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration
What to do
Voluntary: Firm initiated · Letter
Get an email if DIHYDROERGOTAMINE MESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIHYDROERGOTAMINE MESYLATE
- Manufacturer
- Provepharm Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0381284411059
- Lot
- Lot #: F9026F01, F9026F02, Exp. Date 12/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279December 25, 2024
- FDAVCF, Vaginal Contraceptive Gel, Birth Control, 10 Pre-filled Applicators, Net Wt. 0.09 oz (2.55g) Each,December 25, 2024
- FDAHenry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl. oz. (29.6 mL), Distributed by HenryDecember 25, 2024
- FDALITE Regener-Eyes, Ophthalmic Solution (glycerin 0.4%), 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL;December 25, 2024
- FDAIpana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada.December 25, 2024
- FDAPROFESSIONAL Regener-Eyes, Ophthalmic Solution (glycerin 0.5%) , 3mL bottles, Distributed by: Regener-Eyes,December 25, 2024
Questions about this recall
Was Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05 recalled?
Yes. FDA published recall D-0150-2025 on December 25, 2024. Reported hazard: Discoloration
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIHYDROERGOTAMINE MESYLATE. UPC: 0381284411059.